On April 22, British Medical released the first quarter report of 2021, and the company realized operating income of RMB 6.735 billion during the reporting period, an increase of 770.86% year-on-year; The net profit attributable to the shareholders of the listed company was 3.736 billion yuan, an increase of 2791.66% year on year; Net cash flow from operating activities was 3.075 billion yuan, an increase of 1013.67% year-on-year. Benefited from the strong demand for disposable gloves at home and abroad, and the annual production capacity of 9billion nitrile gloves added in Anhui production base of the company, the company's profit in the first quarter increased by 41.80% on a year basis, and the performance of the single quarter was more innovative.

As a leading supplier of comprehensive medical care products, the British medical business is worldwide. The company mainly covers four major parts: personal protection, rehabilitation nursing, health care, physical therapy and inspection consumables. The main products include disposable nitrile gloves, disposable PVC gloves, manual wheelchair, electric intelligent wheelchair, walking aid, walking aid, walking aid, medical bedside table, cold hot compress, electrode piece, washfree disinfectant, etc., which are widely used in medical institutions, elderly care institutions Household daily use and other related industries. Through disposable gloves business, the company has served more than 10000 customers in more than 120 countries and regions, and has a deep channel resources covering the world, which greatly helps the company to carry out sales activities of multi-product consumables, equipment and equipment.

At present, the company is accelerating the construction of Zhenjiang R & D production base in Jiangsu Province, and has completed the capacity construction of 1 million rehabilitation treatment intelligent devices per year, and has become one of the best R & D and production bases of rehabilitation devices in the world, according to Yingke medical. With the aging of population, the number of people who are not easy to move is becoming larger and larger. The products of rehabilitation care have a wide market space in the world. The company will increase marketing and brand marketing in the future. Based on the advantages of the company's many years of export of rehabilitation equipment and the advantages of OEM for many foreign brands, the company will reduce production cost through automation and scale advantages, and actively improve the market share of rehabilitation and nursing products.

It is worth mentioning that, according to the company's strategic development needs, the company has realized the integration of supply chain and ensured the sufficient and stable supply of upstream raw materials. Anhui Yingke, a wholly-owned subsidiary of the company, invested 700million yuan to build 500000 tons of carboxyl butyronitrile latex and 100000 tons DOTP project by establishing a holding subsidiary Anhui kaize. With the company continuing to extend to the upstream raw materials and other fields, the cost advantage will gradually improve, and the comprehensive competitiveness of products is expected to continue to strengthen.

Industry insiders said that in 2020, the revenue and profit performance of British medical equipment company ranked first among domestic medical devices companies. From the asset level, the net assets of the company at the end of the first quarter reached 13.314 billion yuan, an increase of 40.34% compared with the end of 2020. The company's asset scale is also expected to reach the top level of domestic medical equipment enterprises in 1-2 years. In the future, British Medical will make reasonable use of the sufficient capital brought by strong profitability, and gradually grow into a world-class medical consumables and equipment high-tech enterprise with strong sales channels and manufacturing resources with Chinese advantages in more than 120 countries and regions.